¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦59ȸ Ãß°è±¹Á¦Çмú´ëȸ (1ÀÏÂ÷) : 2023-11-03

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

Á¦59ȸ Ãß°è±¹Á¦Çмú´ëȸ (1ÀÏÂ÷) : 2023-11-03
±³À°ÀÏÀÚ : 2023-11-03
±³À°Àå¼Ò : ¼­¿ï, ÄÜ·¡µåÈ£ÅÚ(¿©Àǵµ) 3Ãþ

±³À°ÁÖÁ¦ : (¿ÀÇÁ¶óÀÎ) Á¦59ȸ Ãß°è±¹Á¦Çмú´ëȸ (1ÀÏÂ÷)

ÁÖÃÖ±â°ü : ´ëÇÑ°íÇ÷¾ÐÇÐȸ
´ã´çÀÚ : ¼­Áö¿ø
¿¬¶ôó : 02-565-3350  

À̸ÞÀÏ : ksh@koreanhypertension.org

±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, »êºÎÀΰú, ½Å°æ°ú, °¡Á¤ÀÇÇаú, »ý¸®ÇÐ, ¾à¸®ÇÐ

Âü¼®¿¹»óÀÎ : 800¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 0ºÐ

¼¼ºÎ¼ö°­·á : 100,000¿ø  

ºñ°í "*»çÀüµî·Ï: Á¤È¸¿ø(6¸¸¿ø), Á¤È¸¿ø ¿Ü(8¸¸¿ø), ÀüÀÓÀÇ ¹× ±âŸ(4¸¸¿ø), °£È£»ç/¿µ¾ç»ç/¾à»ç/Àü°øÀÇ(2¸¸¿ø), ´ëÇлý_´ëÇпø»ý Á¦¿Ü(º¸°Ç´ë/°£È£´ë/ÀÇ´ë)(¹«·á), 65¼¼ ÀÌ»ó Á¤È¸¿ø(¹«·á)

*ÇöÀåµî·Ï: Á¤È¸¿ø(8¸¸¿ø), Á¤È¸¿ø ¿Ü(10¸¸¿ø), ÀüÀÓÀÇ ¹× ±âŸ(5¸¸¿ø), °£È£»ç/¿µ¾ç»ç/¾à»ç/Àü°øÀÇ(2¸¸¿ø), ´ëÇлý_´ëÇпø»ý Á¦¿Ü(º¸°Ç´ë/°£È£´ë/ÀÇ´ë)(¹«·á), 65¼¼ ÀÌ»ó Á¤È¸¿ø(¹«·á)"  


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 11¿ù 03ÀÏ ROOM A 09:15~09:30 Pathophysiology of Hypertension for Novel Treatment À±Á¾Âù(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 11¿ù 03ÀÏ ROOM A 09:30~09:45 Development of Therapeutic Vaccine for Hypertension Hironori Nakagami(japan)

±³À°½Ã°£ 11¿ù 03ÀÏ ROOM A 09:45~10:00 SiRNA and Other Novel Therapeutics for Hypertension À§Áø(°¡ÃµÀÇ´ë)

±³À°½Ã°£ 11¿ù 03ÀÏ ROOM A 10:00~10:15 Device Therapies of Hypertension ±èº´±Ø(¿¬¼¼ÀÇ´ë)

Åä·Ð 11¿ù 03ÀÏ ROOM A 10:15~10:30 Åä·Ð Á¶ÀÎÁ¤, ÃÖ¼ºÈÆ, Çã¶õ(ÀÌÈ­ÀÇ´ë, ÇѸ²ÀÇ´ë, ÇѾçÀÇ´ë)

±³À°½Ã°£ 11¿ù 03ÀÏ ROOM A 10:50~11:10 Intensive Treatment Strategy in Hypertension Áö¿µ¹Ì(Áúº´°ü¸®Ã»Àå)

±³À°½Ã°£ 11¿ù 03ÀÏ ROOM D 11:20~11:35 °íÇ÷¾Ð ȯÀÚÀÇ Ç¥ÀûÀå±â ¼Õ»ó Æò°¡ Á¶ÀºÁÖ(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 11¿ù 03ÀÏ ROOM D 11:35~11:50 °íÇ÷¾Ð ȯÀÚÀÇ Ç÷¾Ð ÃøÁ¤ ÀÌÀº¹Ì(¿ø±¤ÀÇ´ë)

±³À°½Ã°£ 11¿ù 03ÀÏ ROOM D 11:50~12:05 °íÇ÷¾Ð ȯÀÚÀÇ ÈçÇÑ Áú¹®°ú ´ë´ä ÀÌÇØ¿µ(¼­¿ïÀÇ´ë)

Åä·Ð 11¿ù 03ÀÏ ROOM D 12:05~12:30 Åä·Ð ÀÓ»óÇö, ÇÏÁ¾¿ø(°¡Å縯ÀÇ´ë, ¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 11¿ù 03ÀÏ ROOM A 12:40~13:10 Importance of 24h BP Control for Reducing CVD Risk: The Role of Edarbi À̼÷Áø(ÇѸ²ÀÇ´ë)

±³À°½Ã°£ 11¿ù 03ÀÏ ROOM A 13:35~13:50 Prevalence and Management of Hypertension in the US Daichi Shimbo(USA)

±³À°½Ã°£ 11¿ù 03ÀÏ ROOM A 13:50~14:05 Prevalence and Management of Hypertension in Europe Neil Poulter(UK)

±³À°½Ã°£ 11¿ù 03ÀÏ ROOM A 14:05~14:20 Prevalence and Management of Hypertension in Singapore Chadachan Veerendra(Singapore)

±³À°½Ã°£ 11¿ù 03ÀÏ ROOM A 14:20~14:35 Prevalence and Management of Hypertension in Korea ÀÌÈ£±Ô(¿¬¼¼ÀÇ´ë)

Åä·Ð 11¿ù 03ÀÏ ROOM A 14:35~14:50 Åä·Ð ±èÇзÉ, ÀÌÁÖ¹Ì(¼­¿ïÀÇ´ë, Ãæ³²ÀÇ´ë)

±³À°½Ã°£ 11¿ù 03ÀÏ ROOM A 15:00~15:15 Association between BP Variability and Ischemic Stroke ÀÌÈñ¼±(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 11¿ù 03ÀÏ ROOM A 15:15~15:30 BP Variability and Parkinson ±Ç°âÀÏ(¼øõÇâÀÇ´ë)

±³À°½Ã°£ 11¿ù 03ÀÏ ROOM A 15:30~15:45 BP Management in Patient with Cognitive Impairment/Dementia ±èÇöÁø(ÇѾçÀÇ´ë)

±³À°½Ã°£ 11¿ù 03ÀÏ ROOM A 15:45~16:00 Evolved Adaptations in the Giraffe : A Blueprint for Biomedical Innovation Babara Natterson-Horowitz(USA)

Åä·Ð 11¿ù 03ÀÏ ROOM A 16:00~16:15 Åä·Ð ±è¹üÁØ, ¹è´ëȯ(¿ï»êÀÇ´ë, ÃæºÏÀÇ´ë)

±³À°½Ã°£ 11¿ù 03ÀÏ ROOM A 16:25~16:40 Chronic Kidney Disease and Hypertension : New Clinical Updates Á¤¼ºÁø(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 11¿ù 03ÀÏ ROOM A 16:40~16:55 Hypertension and Stroke in Asia Yuda Turana(Indonesia)

±³À°½Ã°£ 11¿ù 03ÀÏ ROOM A 16:55~17:10 Impact of Anti-hypertensive Therapy on Cerebral Function Networks and Connectivity Giuseppe Lembo(Italy)

±³À°½Ã°£ 11¿ù 03ÀÏ ROOM A 17:10~17:25 Hypertension Management in AF Patients ¹Ú¼ºÇÏ(¿¬¼¼ÀÇ´ë)

Åä·Ð 11¿ù 03ÀÏ ROOM A 17:25~17:40 Åä·Ð ¼­Çý¼±, ÀÓÀ缺, õ´ë¿µ(¼øõÇâÀÇ´ë, ¿ï»êÀÇ´ë, ÇѸ²ÀÇ´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦59ȸ Ãß°è±¹Á¦Çмú´ëȸ (1ÀÏÂ÷) : 2023-11-03""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Á¦75Â÷ ´ëÇѺñ´¢ÀÇÇÐȸ Á¤±âÇмú´ëȸ (DAY3) : 2023-11-03
´ÙÀ½±Û (¿Â¶óÀÎ) ¾îÁö·³°ú À̸í, ÀÌ°ú Áúȯ¿¡¼­ »ç¿ëÇÏ´Â ´Ù¾çÇÑ Ç÷°üÈ®ÀåÁ¦¿Í ³ú±â´É°³¼±Á¦, Ç׿ì¿ïÁ¦ : 2023-11-02
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20913 ¼­¿ï 2024 ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸ ¿¬¼ö°­Á : 2024-07-13 0 41 2024-05-28
20912 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦3Â÷¿¬¼ö±³À° : 2024-07-11 0 46 2024-05-28
20911 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-08 0 48 2024-05-28
20910 ¼­¿ï 2024³â Á¦14ȸ °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ³»ºÐºñ³»°ú ¿¬¼ö°­Á : 2024-07-07 0 24 2024-05-28
20909 °æ±â ¾ÆÁÖ´ëÇб³º´¿ø Á¤Çü¿Ü°ú 30Áֳ⠱â³ä ½ÉÆ÷Áö¿ò : 2024-07-07 0 27 2024-05-28
20908 ¼­¿ï Á¦19Â÷ ´ëÇѸðÀ¯¼öÀ¯ÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-07-07 0 18 2024-05-28
20907 °æ±â Á¦2Â÷ ´ëÇѽŰæ¹æ»ç¼±¼ö¼úÇÐȸ Á¤±âÇмú´ëȸ : 2024-07-06 0 16 2024-05-28
20906 °æ±â Á¦ 5ȸ ¿À»ê½ÃÀÇ»çȸ Çмú´ëȸ : 2024-07-06 0 18 2024-05-28
20905 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø Á¦3ȸ ¾Æ»êµÎ°æºÎ Æ÷·³ : 2024-07-06 0 21 2024-05-28
20904 ¼­¿ï 2024³â Á¦2ȸ °¡Å縯´ëÇб³ ÀºÆò¼º¸ðº´¿ø ¼øȯ±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-06 0 25 2024-05-28
20903 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day3) : 2024-07-06 0 20 2024-05-28
20902 ¼­¿ï ´ëÇѽŰæÁýÁßÄ¡·áÇÐȸ 2024³â ÇÏ°è NeurocrItical Care Essence (NICE) ¾ÆÄ«µ¥¹Ì : 2024-07-06 0 13 2024-05-28
20901 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø Á¦10ȸ ºÎ½Å¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-07-06 0 16 2024-05-28
20900 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day2) : 2024-07-05 0 7 2024-05-28
20899 ¼­¿ï ÀÓ»ó¼ú±â±³À°¿¬±¸È¸ Á¦16ȸ ÀÓ»ó¼ú±â ¿¬¼ö°­Á : 2024-07-04 0 18 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷